Zynerba Pharmaceuticals, Inc. (ZYNE) - Balance Sheet Statement

Home
ZYNE
Financials

1.3 (USD) • At close October 10, 2023

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	50.641	67.808	59.157	70.063	59.764	62.51	30.966	41.513	9.331	0.155
Short Term Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Cash and Short Term Investments Numbers are in millions	50.641	67.808	59.157	70.063	59.764	62.51	30.966	41.513	9.331	0.155
Net Receivables Numbers are in millions	0	0	0	0	0	0	0	0	0	0.035
Inventory Numbers are in millions	0	0	0	0	0	0	0	1.494	0	0
Other Current Assets Numbers are in millions	4.134	12.412	14.209	16.993	7.192	5.717	5.445	1.903	1.08	0
Total Current Assets Numbers are in millions	54.775	80.22	73.366	87.056	66.955	68.228	36.411	43.416	11.595	0.689
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	0.746	0.952	0.691	0.709	0.372	0.165	0.143	0.228	0.02	0.048
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0	0	0	0	0	0.662	0	0	0.002	1.124
Total Non-Current Assets Numbers are in millions	0.746	0.952	0.691	0.709	0.372	0.827	0.144	0.228	0.022	1.172
Total Assets Numbers are in millions	55.521	81.172	74.057	87.765	67.327	69.054	36.554	43.644	11.617	1.861
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	1.943	1.799	2.523	4.741	4.462	3.355	1.848	0.823	0.314	0.308
Short Term Debt Numbers are in millions	0.215	0.209	0.11	0.244	0	0	0	0	0	0.125
Tax Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0	0	0.172	0.834	0.841	1.12	1.041
Other Current Liabilities Numbers are in millions	7.015	7.897	11.281	7.074	5.264	3.915	4.285	2.273	1.711	0.088
Total Current Liabilities Numbers are in millions	9.173	9.904	13.913	12.058	9.726	7.443	6.967	3.938	3.146	1.562
Non-Current Liabilities:
Long Term Debt Numbers are in millions	0.12	0.354	0	0.11	0	0	0	0	0	0.375
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0.662	0	0	0	1.12
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Total Non-Current Liabilities Numbers are in millions	0.12	0.354	0	0.11	0	0.662	0	0	16.523	1.495
Total Liabilities Numbers are in millions	9.292	10.258	13.913	12.168	9.726	8.105	6.967	3.938	19.668	3.058
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	3.162
Common Stock Numbers are in millions	0.048	0.041	0.03	0.023	0.018	0.014	0.01	0.009	0.002	0
Retained Earnings Numbers are in millions	-274.517	-239.481	-202.172	-150.836	-117.892	-77.981	-45.969	-22.58	-10.029	-4.359
Accumulated Other Comprehensive Income/Loss Numbers are in millions	0	0	0	0	-0.263	0	0	0	0	0
Other Total Stockholders Equity Numbers are in millions	320.698	310.354	262.286	226.409	175.476	138.917	75.546	62.277	1.975	0
Total Shareholders Equity Numbers are in millions	46.229	70.913	60.144	75.597	57.602	60.95	29.587	39.706	-8.052	-1.197
Total Equity Numbers are in millions	46.229	70.913	60.144	75.597	57.602	60.95	29.587	39.706	-8.052	-1.197
Total Liabilities & Shareholders Equity Numbers are in millions	55.521	81.172	74.057	87.765	67.327	69.054	36.554	43.644	11.617	1.861

Zynerba Pharmaceuticals, Inc.

NASDAQ:ZYNE Add to watchlist

NASDAQ:ZYNE